FDA Inspection 1267810 — Island Reproductive Services
The FDA completed an inspection of Island Reproductive Services on Apr 17, 2025 in Staten Island, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 17, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Staten Island, NY (United States)